Ozanimod Hydrochloride | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ozanimod Hydrochloride
Europe

Evonik

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

Ozanimod Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 6 USDMF, 1 EU WC, 8 NDC API, 9 Listed Suppliers, $ API Reference Price

19 API Suppliers
6 USDMF
1 EU WC
8 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

73 Drugs in Development

73 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

20 FDF Dossiers, 5 FDA Orange Book, 7 Europe, 5 Australia, 3 Listed Dossiers

20 FDF Dossiers
5 FDA Orange Book
7 Europe
5 Australia
3 Listed Dossiers

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 65 News #PharmaBuzz

1 Stock Recap #PipelineProspector
65 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Annual Reports

1 US Medicaid Prescriptions
5 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

18 US Patents, 6 US Exclusivities, 6 Health Canada Patents

18 US Patents
6 US Exclusivities
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 257,511 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 4Bristol-Myers Squibb Pharma Eeig

02 3Bristol-Myers Squibb Sa

filter Active Ingredients Reset all filters

7 All

01 3Ozanimod

02 4Ozanimod Hydrochloride

filter Dosage Form Reset all filters

7 All

01 2Capsule

02 5Hard Capsule

filter Country Reset all filters

7 All

01 2Spain

02 2Sweden

03 3Switzerland

filter Brand Name Reset all filters

7 All

01 7Zeposia

List of Suppliers

Product Main Page

01

Bristol-Myers Squibb Sa

Pharma MES 2025

Not Confirmed

Bristol-Myers Squibb Sa

Pharma MES 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Brand Name : Zeposia

Dosage Form : Hard Capsule

Dosage Strength : 0.23mg

Packaging :

Approval Date : 11/08/2020

Application Number : 67046

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bristol-Myers Squibb Sa

Pharma MES 2025

Not Confirmed

Bristol-Myers Squibb Sa

Pharma MES 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Brand Name : Zeposia

Dosage Form : Hard Capsule

Dosage Strength : 0.46mg

Packaging :

Approval Date : 11/08/2020

Application Number : 67046

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bristol-Myers Squibb Sa

Pharma MES 2025

Not Confirmed

Bristol-Myers Squibb Sa

Pharma MES 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Brand Name : Zeposia

Dosage Form : Hard Capsule

Dosage Strength : 0.92mg

Packaging :

Approval Date : 11/08/2020

Application Number : 67046

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Ozanimod Hydrochloride

Brand Name : Zeposia

Dosage Form : Capsule

Dosage Strength : 0.23mg, 0.46mg

Packaging :

Approval Date : 20/05/2020

Application Number : 20190307000057

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Ozanimod Hydrochloride

Brand Name : Zeposia

Dosage Form : Capsule

Dosage Strength : 0.92mg

Packaging :

Approval Date : 20/05/2020

Application Number : 20190312000103

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Ozanimod Hydrochloride

Brand Name : Zeposia

Dosage Form : Hard Capsule

Dosage Strength : 0.23MG; 0.46 MG

Packaging :

Approval Date : 2020-06-25

Application Number : 1201442001

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Bristol-Myers Squibb Pharma Eeig

Pharma MES 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Ozanimod Hydrochloride

Brand Name : Zeposia

Dosage Form : Hard Capsule

Dosage Strength : 0.92MG

Packaging :

Approval Date : 2020-06-25

Application Number : 1201442002

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!